Joakim Bergman

438 total citations
8 papers, 348 citations indexed

About

Joakim Bergman is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Joakim Bergman has authored 8 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 5 papers in Neurology and 3 papers in Oncology. Recurrent topics in Joakim Bergman's work include Multiple Sclerosis Research Studies (8 papers), Polyomavirus and related diseases (3 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). Joakim Bergman is often cited by papers focused on Multiple Sclerosis Research Studies (8 papers), Polyomavirus and related diseases (3 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). Joakim Bergman collaborates with scholars based in Sweden and United Kingdom. Joakim Bergman's co-authors include Anders Svenningsson, Tommy Bergenheim, Ann Dring, Jonathan D. Gilthorpe, Henrik Zetterberg, Kaj Blennow, Niklas Norgren, Thomas Lindqvist, Richard Birgander and Joachim Burman and has published in prestigious journals such as Neurology, Journal of Neurology and Multiple Sclerosis Journal.

In The Last Decade

Joakim Bergman

8 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joakim Bergman Sweden	6	186	145	79	72	72	8	348
Johanna Oechtering Switzerland	12	200 1.1×	115 0.8×	45 0.6×	86 1.2×	45 0.6×	22	358
Elisabet Matas Spain	11	306 1.6×	128 0.9×	64 0.8×	64 0.9×	65 0.9×	23	419
Shrishti Saxena United States	12	252 1.4×	126 0.9×	42 0.5×	149 2.1×	84 1.2×	27	450
Laura Bau Spain	11	315 1.7×	143 1.0×	64 0.8×	64 0.9×	61 0.8×	24	405
M. Alba Mañé-Martínez Spain	7	205 1.1×	103 0.7×	33 0.4×	52 0.7×	46 0.6×	10	270
E. P. Evdoshenko Russia	8	265 1.4×	153 1.1×	40 0.5×	71 1.0×	65 0.9×	34	364
Ariele L. Greenfield United States	7	182 1.0×	107 0.7×	168 2.1×	60 0.8×	67 0.9×	9	399
Johan Mellergård Sweden	10	215 1.2×	63 0.4×	145 1.8×	88 1.2×	80 1.1×	22	394
Karim L. Kreft Netherlands	13	151 0.8×	52 0.4×	141 1.8×	104 1.4×	59 0.8×	24	408
Vanessa Daccach Marques Brazil	14	330 1.8×	263 1.8×	58 0.7×	96 1.3×	44 0.6×	32	522

Countries citing papers authored by Joakim Bergman

Since Specialization

Citations

This map shows the geographic impact of Joakim Bergman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joakim Bergman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joakim Bergman more than expected).

Fields of papers citing papers by Joakim Bergman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joakim Bergman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joakim Bergman. The network helps show where Joakim Bergman may publish in the future.

Co-authorship network of co-authors of Joakim Bergman

This figure shows the co-authorship network connecting the top 25 collaborators of Joakim Bergman. A scholar is included among the top collaborators of Joakim Bergman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joakim Bergman. Joakim Bergman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Bergman, Joakim, Anders Svenningsson, Per Liv, Tommy Bergenheim, & Joachim Burman. (2020). Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS. Fluids and Barriers of the CNS. 17(1). 49–49. 11 indexed citations

Bergman, Joakim, Joachim Burman, Tommy Bergenheim, & Anders Svenningsson. (2020). Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension. Journal of Neurology. 268(2). 651–657. 5 indexed citations

Bergman, Joakim, Anders Svenningsson, Per Liv, & Joachim Burman. (2019). Poor correlation between protein levels in different CNS compartments in patients with progressive MS. Multiple Sclerosis Journal. 25. 432–433. 1 indexed citations

Bergman, Joakim, Joachim Burman, Jonathan D. Gilthorpe, et al.. (2018). Intrathecal treatment trial of rituximab in progressive MS. Neurology. 91(20). e1893–e1901. 32 indexed citations

Nimer, Faiez Al, Christina Elliott, Joakim Bergman, et al.. (2016). Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination. Neurology Neuroimmunology & Neuroinflammation. 3(1). e191–e191. 63 indexed citations

Bergman, Joakim, Ann Dring, Henrik Zetterberg, et al.. (2016). Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS. Neurology Neuroimmunology & Neuroinflammation. 3(5). e271–e271. 125 indexed citations

Flon, Pierre de, Martin Gunnarsson, Katarina Laurell, et al.. (2016). Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab. Neurology. 87(2). 141–147. 74 indexed citations

Svenningsson, Anders, Joakim Bergman, Ann Dring, et al.. (2015). Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally. Neurology Neuroimmunology & Neuroinflammation. 2(2). e79–e79. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact